Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Setmelanotide shows promise for hypothalamic obesity after brain tumors

Summary by News Medical
A new therapy helps achieve a healthier BMI in people whose weight has become dysregulated following treatment for a brain tumor, a clinical trial has found.

4 Articles

Lean Right

There is a glimmer of hope for severely obese children and adults struggling with extreme hunger pangs due to brain damage. An effective treatment appears to have been found for this rare but life-threatening form of obesity. This is evident from a publication regarding an international study in The New England Journal of Medicine. In that study using the drug setmelanotide, all patients, including a large proportion of children, lost many kilo…

·Netherlands (Kingdom of the)
Read Full Article
gelderlander.nlgelderlander.nl
Reposted by
destentor.nldestentor.nl

For people with brain damage caused by a tumor that results in obesity, a new drug may offer a solution. They could lose many kilograms after a year. This is according to research published Thursday in the New England Journal of Medicine.

·Nijmegen, Netherlands (Kingdom of the)
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center, 50% of the sources lean Right
50% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

News Medical broke the news in United States on Thursday, July 9, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal